Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Trimarchi

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Cancer Cell|October 20, 2012
Therapeutic targeting of the cyclin D3:CDK4/6 complex in T cell leukemiaCatherine M Sawai, Jacquelyn Freund, Philmo Oh, et al.
Cell|June 25, 2013
The ubiquitin ligase FBXW7 modulates leukemia-initiating cell activity by regulating MYC stabilityBryan King, Thomas Trimarchi, Linsey Reavie, et al.
Nature Cell Biology|October 28, 2016
Regulation of transcriptional elongation in pluripotency and cell differentiation by the PHD-finger protein Phf5aAlexandros Strikoudis, Charalampos Lazaris, Thomas Trimarchi, et al.
Cancer Cell|June 10, 2015
CXCL12-Producing Vascular Endothelial Niches Control Acute T Cell Leukemia MaintenanceLauren A Pitt, Anastasia N Tikhonova, Hai Hu, et al.
Nature Cell Biology|February 28, 2015
FBXW7 modulates cellular stress response and metastatic potential through ​HSF1 post-translational modificationNikos Kourtis, Rana S Moubarak, Beatriz Aranda-Orgilles, et al.
Nature Medicine|July 25, 2018
Oncogenic hijacking of the stress response machinery in T cell acute lymphoblastic leukemiaNikos Kourtis, Charalampos Lazaris, Kathryn Hockemeyer, et al.
Nature Immunology|April 14, 2015
TET1 is a tumor suppressor of hematopoietic malignancyLuisa Cimmino, Meelad M Dawlaty, Delphine Ndiaye-Lobry, et al.
Nature Immunology|July 22, 2015
Erratum: TET1 is a tumor suppressor of hematopoietic malignancyLuisa Cimmino, Meelad M Dawlaty, Delphine Ndiaye-Lobry, et al.
Nature|May 13, 2011
A novel tumour-suppressor function for the Notch pathway in myeloid leukaemiaApostolos Klinakis, Camille Lobry, Omar Abdel-Wahab, et al.
Cancer Cell|September 14, 2010
The Notch/Hes1 pathway sustains NF-κB activation through CYLD repression in T cell leukemiaLluis Espinosa, Severine Cathelin, Teresa D'Altri, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Cancer Cell|October 20, 2012
Therapeutic targeting of the cyclin D3:CDK4/6 complex in T cell leukemiaCatherine M Sawai, Jacquelyn Freund, Philmo Oh, et al.
Cell|June 25, 2013
The ubiquitin ligase FBXW7 modulates leukemia-initiating cell activity by regulating MYC stabilityBryan King, Thomas Trimarchi, Linsey Reavie, et al.
Nature Cell Biology|October 28, 2016
Regulation of transcriptional elongation in pluripotency and cell differentiation by the PHD-finger protein Phf5aAlexandros Strikoudis, Charalampos Lazaris, Thomas Trimarchi, et al.
Cancer Cell|June 10, 2015
CXCL12-Producing Vascular Endothelial Niches Control Acute T Cell Leukemia MaintenanceLauren A Pitt, Anastasia N Tikhonova, Hai Hu, et al.
Nature Cell Biology|February 28, 2015
FBXW7 modulates cellular stress response and metastatic potential through ​HSF1 post-translational modificationNikos Kourtis, Rana S Moubarak, Beatriz Aranda-Orgilles, et al.
Nature Medicine|July 25, 2018
Oncogenic hijacking of the stress response machinery in T cell acute lymphoblastic leukemiaNikos Kourtis, Charalampos Lazaris, Kathryn Hockemeyer, et al.
Nature Immunology|April 14, 2015
TET1 is a tumor suppressor of hematopoietic malignancyLuisa Cimmino, Meelad M Dawlaty, Delphine Ndiaye-Lobry, et al.
Nature Immunology|July 22, 2015
Erratum: TET1 is a tumor suppressor of hematopoietic malignancyLuisa Cimmino, Meelad M Dawlaty, Delphine Ndiaye-Lobry, et al.
Nature|May 13, 2011
A novel tumour-suppressor function for the Notch pathway in myeloid leukaemiaApostolos Klinakis, Camille Lobry, Omar Abdel-Wahab, et al.
Cancer Cell|September 14, 2010
The Notch/Hes1 pathway sustains NF-κB activation through CYLD repression in T cell leukemiaLluis Espinosa, Severine Cathelin, Teresa D'Altri, et al.
Pageof 3